Feb 20, 2018ACQUISITIONUnited Kingdom MicroPort and Yunfeng Capital to acquire LivaNova's CRM business for $190 million
MicroPort Scientific Corporation and Chinese PE firm Yunfeng Capital will acquire the cardiac rhythm management (CRM) business of LivaNova for $190 million in cash.
Productscardiac rhythm management devices
“Hong Kong-listed medical device manufacturer MicroPort Scientific Corporation and Chinese PE firm Yunfeng Capital will acquire the cardiac rhythm management (CRM) business of US-listed medical technology company LinaNova for $190 million in cash.”dealstreetasia.com
- 3 sources
- dealstreetasia.comMicroPort partners China's Yunfeng to buy business franchise of LivaNova for $190mFeb 23, 2018
- chinalawinsight.comKing & Wood Mallesons advises Yunfeng Fund and MicroPort jointly acquired LivaNova PLC’s cardiac rhythm management business ranking fifth largest in the world | China Law InsightKing &, WoodMar 8, 2018
- vascularnews.comBehind the MiCroPort acquisition of Lombard Medical: What is next? - Vascular NewszohmanDec 11, 2018
Summarized from public sources; check the original articles before acting on it.
ENDATA